Metabolic Health

The most common undiagnosed condition in adults is not a disease. It is metabolic drift, and weight is often the first visible sign of it.

Key takeaways

  • Metabolic dysfunction is measurable years before blood glucose becomes abnormal.
  • Fasting insulin and HOMA-IR are the earliest reliable signals, and most standard panels omit both.
  • Normal reference ranges describe a population that already includes unwell people. Optimal is a different target.
  • Almost everything that improves metabolic health is repeatable: sleep, Zone 2 cardio, protein and fiber, alcohol reduction.

Metabolic health describes how efficiently your body regulates blood sugar, insulin, and energy use, the foundation underneath weight, energy levels, and long term disease risk.

Conventional medicine measures blood glucose and calls it a metabolic panel. Fasting insulin and HOMA-IR tell a different story, one that often builds silently for years before blood glucose becomes abnormal. Baseline tracks these early signals and supports root cause evaluation instead of waiting for a threshold to be crossed.

Most people who seek metabolic and weight loss support have already been told their labs are normal. The ranges used to evaluate them are drawn from populations that already include metabolically compromised people. Optimal metabolic function and normal metabolic function are not the same target.

Biomarkers tracked here: Fasting Insulin, HOMA-IR, HbA1c, hsCRP, ApoB, Cystatin C, Fasting Glucose. Full detail on each in the Biomarker Hub below.

What metabolic health actually describes

Metabolic health is how efficiently your body moves fuel where it belongs. Food becomes glucose, insulin escorts that glucose into muscle and liver, and the system resets between meals. When it works, energy is stable, weight is stable, and inflammation stays low. When it drifts, the same amount of insulin buys less and less response, and your pancreas compensates by producing more.

That compensation phase is the important one, because it is silent. Blood glucose stays normal for years while insulin quietly climbs. By the time a routine panel flags glucose, the underlying process has usually been running for a decade.

Why a normal metabolic panel misses it

A standard comprehensive metabolic panel reports fasting glucose. It does not report fasting insulin, and it does not calculate HOMA-IR, the ratio that puts insulin and glucose together. Those two numbers are where early insulin resistance shows up first.

Reference ranges compound the problem. They are built from population data that includes people already on the metabolic decline curve. Being inside the range means you are not an outlier in a broadly unhealthy population. It does not mean your metabolism is performing well.

  • Fasting insulin: most lab reference ranges do not flag anything up to roughly 19 to 25 µIU/mL depending on the lab, while the range worth working toward is 2 to 5.
  • HOMA-IR: standard concern begins near 2.0. Baseline targets under 1.0.
  • HbA1c: standard non-diabetic is under 5.7%. Baseline targets 4.8 to 5.2%.
  • Fasting glucose: standard is under 100 mg/dL. Baseline targets 72 to 85 mg/dL.

What moves the numbers

Insulin sensitivity responds to a small number of inputs, applied consistently. Zone 2 cardio increases the muscle's capacity to take up glucose without insulin doing the work. Resistance training expands the storage tank. Protein and fiber at the front of a meal blunt the glucose curve behind it. Sleep debt and alcohol both degrade next-day insulin sensitivity measurably.

Where lifestyle alone does not close the gap, evaluation may support pharmacologic help, including GLP-1 therapy when clinically appropriate. That decision belongs to a provider reviewing your full panel, not to a protocol template.

How Baseline tracks it

We recommend a metabolic panel at intake, including fasting insulin, HOMA-IR, HbA1c, fasting glucose, hsCRP, ApoB, GGT, and Cystatin C. Where you choose to test, those values are read against optimal targets and turned into a specific plan rather than a generic recommendation to eat better.

We recommend a recheck about a quarter later if you choose to test. The purpose of a recheck is direction, not perfection. A HOMA-IR moving from 2.4 to 1.6 is a working protocol even if it is not yet at target.

What this means for you

If you have been told your labs are normal but your energy, weight, or waistline says otherwise, the most useful next step is measuring fasting insulin and HOMA-IR. They usually explain the gap.

Therapies discussed here

References

  1. Biomarker hub: Metabolic biomarkers
  2. Biomarker hub: Cardiovascular biomarkers

More in Focus areas